Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

C5DC Glutaryl (glutarylcarnitine)

Immunology & Autoimmune

C5-DCGlutarylcarnitine

Review status

Currently under review

Pending specialist review and validation.

What it shows

The C5DC Glutaryl test measures glutarylcarnitine, an acylcarnitine formed when the body links glutaryl-CoA to carnitine during the breakdown of certain amino acids. It reflects how your body processes lysine and tryptophan and how well a specific metabolic pathway is working.

This test is usually performed on blood using tandem mass spectrometry and is often part of an acylcarnitine profile. It helps doctors screen for and evaluate metabolic conditions that can affect energy production, especially in infants and children, and can also be used to monitor known disorders over time.

Why it matters

Glutarylcarnitine can be elevated in glutaric acidemia type I, a rare inherited condition in which an enzyme needed for processing specific amino acids does not work properly. Finding changes early allows prompt dietary management and other treatments that can lower the risk of serious illness and neurological injury, particularly around times of infection or stress.

Your clinician may order this test after a newborn screen, when there are symptoms suggestive of a metabolic disorder, or to follow an established diagnosis. Results are interpreted together with other acylcarnitines, urine organic acids, and genetic or enzyme studies to clarify the cause and guide care.

Understanding your results

Your result is interpreted using age-appropriate reference intervals and your clinical situation. A higher result can suggest a metabolic disorder such as glutaric acidemia type I, but temporary changes can also occur with illness, nutritional status, or certain therapies. A normal result is generally reassuring, yet your care team may still pursue additional tests if symptoms or other findings raise concern.

If your level is outside the expected range, your clinician may order follow-up testing such as urine organic acids, specific biomarkers, and genetic or enzyme analysis. Treatment decisions consider your symptoms, exam findings, and the overall pattern of laboratory results. If you have a known condition, trends over time help assess how well your current management plan is working.

Reference ranges

00.18 umol/L
All sexes
0 days – 7 days
00.12 umol/L
All sexes
7 days – 1 month
00.1 umol/L
All sexes
1 month – 12 months
00.1 umol/L
All sexes
12 months – 13 years
00.12 umol/L
All sexes
13 years – 19 years
0.020.13 umol/L
All sexes
19 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact C5DC Glutaryl (glutarylcarnitine)

  • Age and newborn status

    Glutarylcarnitine levels vary with age, especially in the first weeks of life. Prematurity and the timing of sample collection after birth can influence results, so pediatric ranges are used for interpretation.

  • Illness and catabolic stress

    Fever, fasting, surgery, or infections can shift acylcarnitine patterns by increasing breakdown of body stores. Testing during illness may show transient changes that differ from baseline.

  • Medications and supplements

    Carnitine supplementation, riboflavin therapy, and drugs that affect mitochondrial function or carnitine balance, such as valproate, can alter acylcarnitine profiles and should be shared with your clinician.

  • Sample handling and timing

    Proper collection, prompt processing, and frozen storage help maintain stability of acylcarnitines. Delays, hemolysis, or using an unexpected sample type can affect accuracy.

  • Kidney and liver function

    Changes in kidney excretion or liver metabolism can influence carnitine and acylcarnitine levels. Your care team may consider kidney and liver tests when interpreting results.

2026

References

  1. McGill University Health Centre. (2019, May 21). C5DC Glutaryl (Task CD 709468). Laboratory reference ranges.
  2. American College of Medical Genetics and Genomics. (2020). ACT sheet and algorithm: Elevated C5DC (glutarylcarnitine), consider glutaric acidemia type I.
  3. Boy, N., Mühlhausen, C., Maier, E. M., Heringer, J., Assmann, B., Burgard, P., & Kölker, S. (2017). Proposed recommendations for diagnosing and managing glutaric aciduria type I. Journal of Inherited Metabolic Disease, 40(1), 75–101.